Furacilin Avexima, for topical and external use 20 mg 10 pcs
€5.99 €4.86
An antimicrobial agent, nitrofuran derivative.
Active against Gram-positive bacteria: Staphylococcus spp., Streptococcus spp., Bacillus anthracis; against Gram-negative bacteria: Escherichia coli, Shigella spp., Salmonella spp. (including Salmonella paratyphi).
Indications
Treatment and prevention of purulent-inflammatory processes, incl. purulent wounds, bedsores, burns of II–III degree, blepharitis, conjunctivitis, boil of the external auditory canal;
osteomyelitis, empyema of the paranasal sinuses, pleura (washing the cavities);
acute external and otitis media, tonsillitis, stomatitis, gingivitis;
minor skin damage (including abrasions, scratches, cracks, cuts).
Pharmacological effect
Antimicrobial agent, nitrofuran derivative.
Active against gram-positive bacteria: Staphylococcus spp., Streptococcus spp., Bacillus anthracis; gram-negative bacteria: Escherichia coli, Shigella spp., Salmonella spp. (including Salmonella paratyphi).
Active ingredient
Nitrofural
Composition
1 tab. nitrofural 20 mg.
Excipients:
tartaric acid – 300 mg,
sodium bicarbonate – 390 mg,
sodium carbonate – 330 mg,
sodium chloride – 100 mg,
macrogol 4000 – 60 mg.
Contraindications
Hypersensitivity, bleeding, allergic dermatoses.
Side Effects
Possible: local allergic reactions, dermatitis.
Storage conditions
In a dry place, protected from light and out of reach of children, at a temperature not exceeding 25 °C.
Shelf life
See packaging.
Manufacturer
Irbitsky Chemical Plant, Russia
Shelf life | See on the package. |
---|---|
Conditions of storage | In a dry place, protected from light and out of the reach of children, at a temperature not exceeding 25 °C. |
Manufacturer | Irbit Chemical Plant, Russia |
Medication form | effervescent tablets for preparation of solution for local and external use |
Brand | Irbit Chemical Plant |
Other forms…
Related products
Buy Furacilin Avexima, for topical and external use 20 mg 10 pcs with delivery to USA, UK, Europe and over 120 other countries.